/term/ending-cash-position/BOM:533573 Alembic Pharmaceuticals (BOM:533573) Ending Cash Position
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alembic Pharmaceuticals Ltd (BOM:533573) » Definitions » Ending Cash Position

Alembic Pharmaceuticals (BOM:533573) Ending Cash Position : ₹0 Mil (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Alembic Pharmaceuticals Ending Cash Position?

Alembic Pharmaceuticals's Ending Cash Position for the quarter that ended in Mar. 2024 was ₹0 Mil.

Alembic Pharmaceuticals's annual Ending Cash Position increased from Mar. 2022 (₹611 Mil) to Mar. 2023 (₹755 Mil) and increased from Mar. 2023 (₹755 Mil) to Mar. 2024 (₹1,202 Mil).


Alembic Pharmaceuticals Ending Cash Position Historical Data

The historical data trend for Alembic Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alembic Pharmaceuticals Ending Cash Position Chart

Alembic Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 718.40 980.60 610.90 754.80 1,202.10

Alembic Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Alembic Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Alembic Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Mar. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=754.9+447.2
=1,202

Alembic Pharmaceuticals's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0+0
=0


Alembic Pharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Alembic Pharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Alembic Pharmaceuticals (BOM:533573) Business Description

Traded in Other Exchanges
Address
Alembic Road, Vadodara, GJ, IND, 390 003
Alembic Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company focuses on manufacturing and marketing generic pharmaceutical products across the globe. Alembic also operates a branded formulation business that covers a range of therapeutic areas such as dermatology, oncology, ophthalmology, and injectable formulations. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Alembic Pharmaceuticals (BOM:533573) Headlines

No Headlines